# Rafarm S.A. – FDA Inspection, May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/rafarm-sa/b8f780cb-150f-479c-972b-49798ad3c1d3
Source feed: FDA_Inspections

> FDA inspection 1225663 of Rafarm S.A., May 19, 2023. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225663
- Company Name: Rafarm S.A.
- Inspection Date: 2023-05-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1300434 - 2024-06-21
- FDA Inspection 1155967 - 2021-06-04
- FDA Inspection 1123693 - 2020-03-11
- FDA Inspection 1101881 - 2019-07-30
- [FDA Inspection 1111463 - 2018-05-31](https://www.keypedia.com/records/fda_inspections/rafarm-sa/6429f57b-1cfa-49d1-9f63-9c745663982a)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/hasan-a-irier/8757c2d5-77b0-45a7-b0f2-e42ef3ee306f)

Company: https://www.keypedia.com/companies/rafarm-sa/147e9812-6247-4b31-82b4-c444b23955ce

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c